NYMC > News and Events > NYMC in the News

Bioinc@NYMC Client, Retia Medical, Receives U.S. FDA Clearance for Cardiovascular Monitor

December 21, 2018

BioIncRetia Medical, LLC is the first client at New York Medical College's BioInc@NYMC to obtain FDA approval for a biomedical device. Specifically, Retia Medical has obtained U.S. Food and Drug Administration (FDA) 501(k) clearance for its innovative cardiovascular monitoring system, the Argos Hemodynamic Monitor.

BioInc news: Deborah Novick, director of BioInc@NYMC

Source: Pharmacy Choice